Marina Stantic

1.0k total citations
14 papers, 699 citations indexed

About

Marina Stantic is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Marina Stantic has authored 14 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Marina Stantic's work include Cancer Cells and Metastasis (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and MicroRNA in disease regulation (4 papers). Marina Stantic is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and MicroRNA in disease regulation (4 papers). Marina Stantic collaborates with scholars based in Australia, Czechia and Sweden. Marina Stantic's co-authors include Lan‐Feng Dong, Jiřı́ Neužil, Renata Zobalová, Stephen J. Ralph, Xiufang Wang, Lubomír Procházka, Ladislav Anděra, Paul K. Witting, Pauline Low and Emma Swettenham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Marina Stantic

14 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marina Stantic Australia 12 449 266 225 68 57 14 699
Attila Bíró Hungary 11 320 0.7× 236 0.9× 75 0.3× 180 2.6× 55 1.0× 20 762
Sireesha V. Garimella United States 6 437 1.0× 250 0.9× 130 0.6× 51 0.8× 12 0.2× 11 723
Prahlad V. Raninga Australia 15 533 1.2× 175 0.7× 115 0.5× 78 1.1× 15 0.3× 25 742
Xi Yu China 15 410 0.9× 162 0.6× 227 1.0× 71 1.0× 18 0.3× 43 747
Moriaki Hayashi Japan 15 395 0.9× 201 0.8× 86 0.4× 33 0.5× 79 1.4× 30 761
Lina Han United States 16 439 1.0× 144 0.5× 96 0.4× 90 1.3× 17 0.3× 56 743
Milica Nedeljković Serbia 7 418 0.9× 307 1.2× 228 1.0× 89 1.3× 10 0.2× 13 747
Sophie Roerink Netherlands 8 632 1.4× 300 1.1× 284 1.3× 35 0.5× 9 0.2× 9 1.0k
Ethan B. Butler United States 4 746 1.7× 208 0.8× 553 2.5× 29 0.4× 11 0.2× 6 1.0k

Countries citing papers authored by Marina Stantic

Since Specialization
Citations

This map shows the geographic impact of Marina Stantic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Stantic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Stantic more than expected).

Fields of papers citing papers by Marina Stantic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Stantic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Stantic. The network helps show where Marina Stantic may publish in the future.

Co-authorship network of co-authors of Marina Stantic

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Stantic. A scholar is included among the top collaborators of Marina Stantic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Stantic. Marina Stantic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Stantic, Marina, et al.. (2021). TAp73 represses NF-κB–mediated recruitment of tumor-associated macrophages in breast cancer. Proceedings of the National Academy of Sciences. 118(10). 31 indexed citations
2.
Stantic, Marina, et al.. (2018). ΔNp73 enhances HIF-1α protein stability through repression of the ECV complex. Oncogene. 37(27). 3729–3739. 3 indexed citations
3.
Stantic, Marina, et al.. (2017). ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report. Cellular Oncology. 40(6). 631–638. 16 indexed citations
4.
Yan, Bing, Marina Stantic, Renata Zobalová, et al.. (2015). Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner. BMC Cancer. 15(1). 401–401. 56 indexed citations
5.
Stapelberg, Michael, Martina Bajzíková, Marina Stantic, et al.. (2015). Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents. PLoS ONE. 10(5). e0119549–e0119549. 22 indexed citations
6.
Stantic, Marina, Gema Sanz, Alejandro Fernandez-Woodbridge, et al.. (2014). TAp73 suppresses tumor angiogenesis through repression of proangiogenic cytokines and HIF-1α activity. Proceedings of the National Academy of Sciences. 112(1). 220–225. 50 indexed citations
7.
Zobalová, Renata, Marina Stantic, Michael Stapelberg, et al.. (2011). The Potential Role of CD133 in Immune Surveillance and Apoptosis: A Mitochondrial Connection?. Antioxidants and Redox Signaling. 15(12). 2989–3002. 7 indexed citations
8.
Dong, Lan‐Feng, Ruth Freeman, Ji Liu, et al.. (2009). Suppression of Tumor GrowthIn vivoby the Mitocan α-tocopheryl Succinate Requires Respiratory Complex II. Clinical Cancer Research. 15(5). 1593–1600. 105 indexed citations
9.
Zobalová, Renata, et al.. (2008). CD133-positive cells are resistant to TRAIL due to up-regulation of FLIP. Biochemical and Biophysical Research Communications. 373(4). 567–571. 53 indexed citations
10.
Stantic, Marina, et al.. (2008). Cancer cells with high expression of CD133 exert FLIP upregulation and resistance to TRAIL‐induced apoptosis. BioFactors. 34(3). 231–235. 16 indexed citations
11.
Zobalová, Renata, et al.. (2008). Cancer cells with high expression of CD133 exert FLIP upregulation and resistance to TRAIL-induced apoptosis.. PubMed. 34(3). 231–5. 21 indexed citations
12.
Dong, Lan‐Feng, Emma Swettenham, Xiufang Wang, et al.. (2007). Vitamin E Analogues Inhibit Angiogenesis by Selective Induction of Apoptosis in Proliferating Endothelial Cells: The Role of Oxidative Stress. Cancer Research. 67(24). 11906–11913. 86 indexed citations
13.
Wang, Xiufang, Marc Birringer, Lan‐Feng Dong, et al.. (2007). A Peptide Conjugate of Vitamin E Succinate Targets Breast Cancer Cells with High ErbB2 Expression. Cancer Research. 67(7). 3337–3344. 80 indexed citations
14.
Neužil, Jiřı́, Marina Stantic, Renata Zobalová, et al.. (2007). Tumour-initiating cells vs. cancer ‘stem’ cells and CD133: What’s in the name?. Biochemical and Biophysical Research Communications. 355(4). 855–859. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Attila Bíró Breakdown of academic impact, for papers by Sireesha V. Garimella Breakdown of academic impact, for papers by Prahlad V. Raninga Breakdown of academic impact, for papers by Xi Yu Breakdown of academic impact, for papers by Moriaki Hayashi Breakdown of academic impact, for papers by Lina Han Breakdown of academic impact, for papers by Milica Nedeljković Breakdown of academic impact, for papers by Sophie Roerink Breakdown of academic impact, for papers by Ethan B. Butler
Rankless by CCL
2026